Protein Based Pneumococcal Vaccine (CanSino biologics)

重组肺炎球菌蛋白疫苗（康希诺生物）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameProtein Based Pneumococcal Vaccine (CanSino biologics)
Drug Alias NamePBPV vaccineRecombinant pneumococcal protein vaccinePneumococcal vaccine - Tianjin CanSino Biotechnology
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Bacterial vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRespiratory Tract DiseasesPneumoniaRespiratory Tract Infections +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesTianjin Cansino Biotechnology Inc
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesCanSino Biologics IncTianjin Cansino Biotechnology Inc
Inactive CompaniesN/A
Active IndicationsPneumoniaRespiratory Tract InfectionsPneumococcal Infections
Inactive IndicationsRespiratory Tract Diseases

Other Information

ATC CodeN/A
Related LinksN/A